Related Experiment Video
Updated: Mar 31, 2026

An Intestine/Liver Microphysiological System for Drug Pharmacokinetic and Toxicological Assessment
Published on: December 3, 2020
Predicting Plasma Olanzapine Concentration Following a Change in Dosage: A Population Pharmacokinetic Study
T Tsuboi1, R R Bies2, T Suzuki3
1Department of Neuropsychiatry, Kyorin University School of Medicine, Tokyo, Japan.
Introduction:
Due to high inter-individual variability in peripheral pharmacokinetic parameters, dosing of antipsychotics currently relies on clinical trial-and-error, and predicting antipsychotic plasma concentrations before changing a dose has been a challenge.
Methods:
Patients with schizophrenia receiving a stable dose of olanzapine were included. 2 plasma samples were collected at 2 given time points for the measurement of plasma olanzapine concentrations. At least 7 days after a dosage change of olanzapine, a third sample was collected. The plasma concentration of the third sample was predicted in a blinded fashion using a mixed-effects model with NONMEM(®), using the following information: the 2 baseline plasma concentrations, the interval between the last dose and blood draw, and clinical and demographic information.
Results:
31 subjects (mean±SD age=56.0±11.6; 19 men) were enrolled. The mean prediction (95% confidence interval) errors were 1.6 (-2.8 to 6.0) ng/mL. A highly significant correlation was observed between the observed and predicted concentrations of the third sample (r=0.91, p<0.001).
Discussion:
Plasma olanzapine concentrations following an actual dosage change can be predicted in advance with a high degree of certainty.
Related Concept Videos
Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance
A study on guinea pigs examined the...
Dosage Regimen: Multiple Oral Dosage
Pharmacokinetic–Pharmacodynamic Relationship: Dose to Pharmacological Effect
IV Infusion to Oral Dosing: Conversion Methods
Measurement of Bioavailability: Pharmacokinetic Methods
Bioavailability Study Design: Single Versus Multiple Dose Studies

